| Molecular target . | Effect . | References . |
|---|---|---|
| CB1 | Antagonist, negative allosteric modulator | Laprairie et al., 2015; Thomas et al., 2007 |
| CB2 | Antagonist | Thomas et al., 2007 |
| Nav channels | Inhibitor | Ghovanloo et al., 2018c; Sait et al., 2020 |
| Kv2.1 channel | Inhibitor | Ghovanloo et al., 2018c |
| Cav channels | Inhibitor | Deiana et al., 2012; Ross et al., 2008 |
| TRPV channels | Agonist | Galaj et al., 2020; Bisogno et al., 2001; Pumroy et al., 2019 |
| GPR55 | Antagonist | Harding et al., 2018; Kaplan et al., 2017 |
| Lipid membrane | Decreases elasticity | This study |
| Molecular target . | Effect . | References . |
|---|---|---|
| CB1 | Antagonist, negative allosteric modulator | Laprairie et al., 2015; Thomas et al., 2007 |
| CB2 | Antagonist | Thomas et al., 2007 |
| Nav channels | Inhibitor | Ghovanloo et al., 2018c; Sait et al., 2020 |
| Kv2.1 channel | Inhibitor | Ghovanloo et al., 2018c |
| Cav channels | Inhibitor | Deiana et al., 2012; Ross et al., 2008 |
| TRPV channels | Agonist | Galaj et al., 2020; Bisogno et al., 2001; Pumroy et al., 2019 |
| GPR55 | Antagonist | Harding et al., 2018; Kaplan et al., 2017 |
| Lipid membrane | Decreases elasticity | This study |
Cav, voltage-gated calcium channel; GPR55, G protein–coupled receptor 55; Kv2.1, voltage-gated potassium channel; TRPV, transient receptor potential cation channel.
See de Almeida and Devi (2020) for a more extensive review of CBD targets and signaling pathways.